Dr Mark Payton, CEO of Mercia
The creation of a new UK ‘unicorn’ in the shape of software company Blue Prism highlights the value of patience on the part of investors, according to the Chief Executive of the company’s first investor, Mercia Fund Managers.
As Blue Prism’s market value has risen above $1.0billion, Mercia’s Chief Executive Officer Dr Mark Payton said it showed that tech firms needed access to patient capital to support them at every stage of their development if the UK was to achieve more unicorn companies.
Mercia first invested in Blue Prism in 2004 through its RisingStars Growth Fund and continued to support the company right up until March 2016, when it floated on AIM with an initial market cap of £49.0million. Mercia has realised 75x the fund’s investment cost based on an original investment of £0.9million and continues to hold circa 2.5% stake in the business.
Speaking at Mercia’s annual Gala Dinner in Birmingham, Dr Payton said:
“Mercia was the first investor in Blue Prism and we supported the company throughout. It was 12 years before it floated on AIM and a further two years before we started unwinding our position. During that period we had good times and bad times, but our persistence has paid off. Patience is at the heart of everything we do at Mercia.
“Currently the US dominates the world in terms of the number of unicorn companies it creates. US companies achieve much bigger valuations on flotation, because US funders invest more heavily and look to the long term rather than selling out to a trade buyer at an early stage. The Patient Capital Review has been a real fillip to our industry, but we need to change our approach and recognise the true value of taking a more long-term, strategic approach to supporting technology firms.”
Julian Viggars, Head of Technology Investments at Mercia, said:
“The success of companies like Blue Prism shows that it is possible to build highly scalable, market leading businesses out of the UK’s regions. Alastair and his team are the true pioneers of the Robotic Process Automation software market and the rapid global growth and adoption that is now happening. They are proving the real value in their platform with significant levels of new customer wins and expansion across the US, Asia Pacific and EMEA. Our latest realisation makes for stunning returns for our Fund’s patient investors - some 14 years after they first backed us."
Based in the North West, one of Mercia’s core investment regions, Blue Prism is a leader in robotic process automation, which enables its blue-chip clients to create a digital workforce powered by its software robots that are trained to automate routine back-office clerical tasks.